MGMT and glioblastoma: The epigenetic silencing of the MGMT gene via hypermethylation at the CpG islands of its promoter results in the inactivation of the MGMT gene, which correlates with enhanced TMZ efficacy along with better prognosis in GBM patients [6,58].